Community pharmacist prescribing: $4.4 billion in savings

A pharmacist intervention for patients at high risk of cardiovascular disease both improves patient outcomes and saves money, according to new research Pharmacist researchers from Canada have developed a model that quantifies the savings that a community pharmacist intervention for reducing cardiovascular risk could achieve. The RxEACH study is the largest randomised controlled trial conducted